EAN Webinar Registration

Chair:
Flavio Nobili

Speakers:
Prof. Sebastiaan Engelborghs – Cerebrospinal Fluid biomarkers
Prof. Henryk Barthel – Molecular imaging biomarkers

Learning Objectives:

• Understanding that ‘MCI’ and ‘dementia’ are not final diagnoses but just syndromic ones that should prompt further investigation
• Learning that different biomarker modalities are nowadays available in the clinical context although a shared flow-chart of use in peculiar clinical conditions is not available yet at the European level
• Becoming familiar with the main wet (CSF, blood) and dry (neuroimaging, neurophysiology) biomarkers in the different clinical presentations and with diverging clinical hypotheses

Sebastiaan Engelborghs is full professor of neurology and neurosciences at Vrije Universiteit Brussel (VUB), co-director of the VUB Center for Neurosciences (C4N) and chairman of the neurology department of the VUB university hospital (UZ Brussel). He as well is full professor of neurosciences and neurochemistry at University of Antwerp. He has built up expertise in clinical trials for AD and related disorders for more than 20 years and was PI as well as national or global coordinating physician for several clinical trials, as well as being involved in the design of some of these clinical trials. He is (co-)author on 347 PubMed-cited papers in international peer-reviewed journals which results in 21.256 citations without self-citations, and a WoS h-index of 67 (September 6th, 2021).

Henryk Barthel, MD, is Professor and Assistant Medical Director of the Department of Nuclear
Medicine of the University Hospital Leipzig (Germany). He underwent training in Nuclear Medicine in Heidelberg (Germany) and Leipzig. From 2000 to 2003 he worked as a Research Fellow at the
Imperial College Hammersmith Hospital in London (UK). Dr. Barthel’s current preclinical and clinical research activities focus on new PET imaging techniques to improve diagnosis and treatment in
neurodegenerative diseases and stroke, as well as on hybrid brain PET/MR imaging. To support the general progress of nuclear brain imaging, he serves in the Scientific Program Committees of the 2021 Society of Nuclear Medicine and Molecular Imaging and European Society of Nuclear Medicine (EANM) meetings, is Vice-Chair and Scientific Representative of the EANM Neuroimaging Committee, and is Associate Editor for The Journal of Nuclear Medicine.